Efficacy and safety study of atacicept in patients with Systemic Lupus Erythematosus (ADDRESS II)

Mise à jour : Il y a 4 ans
Référence : EUCTR2013-002773-21

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

Primary: 1. Evaluate the efficacy of atacicept compared to placebo in reducing SLE disease activity in subjects treated with standard of care (SoC) therapy and to investigate the dose-response relationship.


Critère d'inclusion

  • Systemic lupus erythematosus (SLE)